PH010 — Behavioural Activation
Capacity to translate motivation into action, task initiation, and sustained behavioural engagement.
How effectively motivation converts into starting tasks and sustaining behavioural engagement.
Therapeutic areas: TA001 ★TA003TA007
Provenance: Core Version 1 registry phenome for translating motivation into action. Related to Motivation/Drive (PH002) per RF003; distinct as behavioural initiation/engagement rather than intrinsic drive tone. (origin: BRAIN)
Related phenomes: PH002 — Motivation / Drive
External framework cross-references
RDoC domains
- Positive Valence Systems — initial response to reward / action initiation
DSM / ICD context
- Attention-deficit/hyperactivity disorder — hyperactivity/impulsivity
- Major depressive disorder — behavioural activation contexts
Foundational Evidence
Evidence Confidence: Low
Registry-level score for this phenome's foundational evidence stack — not Biology → Phenome Confidence on individual mechanism pages.
Mechanism coverage is thin at registry level; endocannabinoid and dopaminergic reviews provide construct context only — not behavioural-activation intervention evidence.
Registry-level foundational evidence for this phenome. Mechanism pages link to phenome IDs and carry relationship-specific evidence — not duplicated here.
Construct landmark papers
- Covey et al. (2017) — Endocannabinoid system and motivated behaviour / action initiation biology.
- Aquili (2020) — Catecholaminergic signalling and goal-directed behavioural engagement.
Biology → phenome landmark papers
- MacDonald et al. (2024) — Dopamine and initiation of goal-directed action — core activation biology.
- Wurtman et al. (2003) — Dietary precursor effects on catecholamine synthesis upstream of behavioural activation.
Nutrition → biology landmark papers
- Reimherr et al. (1987) — Tyrosine supplementation in ADHD — early human evidence for activation-related biology.
- Wang et al. (2019) — Dietary amino-acid context modulates neurotransmitter biology relevant to task engagement.
Connected mechanisms
- BRS-X(ECS-PM4) — Endocannabinoid–Dopamine Neuromodulation (modulates · low)